topdog52, MNZO Press Releases;
Milford, PA., July 29, 2016 -- Manzo Pharmaceuticals, Inc. (OTCPink:MNZO) announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.
The notice addresses
two press release issues,
Mr. Manzo's accepting and selling unregistered securities in another company prior to his becoming MNZO's CEO,
and certain sales of unregistered securities by others.
Good luck.